Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: All ages
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - ExternalReference:
      DisorderMappingRelation: NTBT (ORPHAcode is narrower than the targeted code
        used to represent it)
      Reference: '187950'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: NTBT (ORPHAcode is narrower than the targeted code
        used to represent it)
      Reference: '601977'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: NTBT (ORPHAcode is narrower than the targeted code
        used to represent it)
      Reference: '614521'
      Source: OMIM
  Genes:
  - Gene:
      DisorderGeneAssociationType: Disease-causing somatic mutation(s) in
      ExternalReferences: []
      Name: Janus kinase 2
      Symbol: JAK2
  - Gene:
      DisorderGeneAssociationType: Disease-causing somatic mutation(s) in
      ExternalReferences: []
      Name: MPL proto-oncogene, thrombopoietin receptor
      Symbol: MPL
  - Gene:
      DisorderGeneAssociationType: Disease-causing somatic mutation(s) in
      ExternalReferences: []
      Name: calreticulin
      Symbol: CALR
  - Gene:
      DisorderGeneAssociationType: Disease-causing somatic mutation(s) in
      ExternalReferences: []
      Name: SH2B adaptor protein 3
      Symbol: SH2B3
  Label: Essential thrombocythemia
  ORPHAcode: '3318'
  ORPHApacketId: '3318'
  PURL: http://www.orpha.net/ORDO/Orphanet_3318
  Parents:
  - Parent:
    - Label: Myeloproliferative neoplasm
      ORPHAcode: '98274'
  - Parent:
    - Label: Rare thrombotic disorder due to an acquired platelet anomaly
      ORPHAcode: '248404'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001892
      HPOTerm: Abnormal bleeding
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002076
      HPOTerm: Migraine
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001658
      HPOTerm: Myocardial infarction
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001872
      HPOTerm: Abnormality of thrombocytes
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001894
      HPOTerm: Thrombocytosis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003010
      HPOTerm: Prolonged bleeding time
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003401
      HPOTerm: Paresthesia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0004420
      HPOTerm: Arterial thrombosis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0004936
      HPOTerm: Venous thrombosis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0005513
      HPOTerm: Increased megakaryocyte count
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0005561
      HPOTerm: Abnormality of bone marrow cell morphology
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0011875
      HPOTerm: Abnormal platelet morphology
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0031388
      HPOTerm: Megakaryocyte nucleus hyperlobulation
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0100576
      HPOTerm: Amaurosis fugax
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0100659
      HPOTerm: Abnormality of the cerebral vasculature
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0100749
      HPOTerm: Chest pain
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001744
      HPOTerm: Splenomegaly
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002315
      HPOTerm: Headache
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002321
      HPOTerm: Vertigo
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100785
      HPOTerm: Insomnia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000505
      HPOTerm: Visual impairment
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000978
      HPOTerm: Bruising susceptibility
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001974
      HPOTerm: Leukocytosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002326
      HPOTerm: Transient ischemic attack
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002488
      HPOTerm: Acute leukemia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002863
      HPOTerm: Myelodysplasia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0011974
      HPOTerm: Myelofibrosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0030243
      HPOTerm: Hepatic vein thrombosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0032147
      HPOTerm: Erythromelalgia
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 18181200[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 16673273[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 16673273[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  Synonyms:
  - Synonym: ET
  - Synonym: Essential thrombocytosis
  TextSection:
    Contents: Essential thrombocythemia (ET) is a myeloproliferative neoplasm (MPN
      see this term) characterized by a sustained elevation of platelet number (>
      450 x 109/L) with a tendency for thrombosis and hemorrhage.
    TextSectionType: Definition
  TypeOfInheritances:
  - TypeOfInheritance:
      value: Multigenic/multifactorial
  - TypeOfInheritance:
      value: Not applicable
  copyright: Orphanet (c) 2024
  creationDate: '2024-12-03 10:13:55'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
